{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:50:04Z","timestamp":1761763804412},"reference-count":118,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,9,1]],"date-time":"1999-09-01T00:00:00Z","timestamp":936144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[1999,9]]},"DOI":"10.1053\/beha.1999.0036","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:49:59Z","timestamp":1027892999000},"page":"451-477","source":"Crossref","is-referenced-by-count":27,"title":["Hyperhomocysteinaemia"],"prefix":"10.1053","volume":"12","author":[{"given":"David J.","family":"Perry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.1999.0036_RF1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0378-4347(87)80438-3","article-title":"Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection","volume":"422","author":"Araki","year":"1987","journal-title":"Journal of Chromatography"},{"key":"10.1053\/beha.1999.0036_RF2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/jn\/124.10.1934","article-title":"Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects","volume":"124","author":"Guttormsen","year":"1994","journal-title":"Journal of Nutrition"},{"key":"10.1053\/beha.1999.0036_RF3","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/clinchem\/39.9.1764","article-title":"Total homocysteine in plasma or serum: methods and clinical applications","volume":"39","author":"Ueland","year":"1993","journal-title":"Clinical Chemistry"},{"key":"10.1053\/beha.1999.0036_RF4","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/clinchem\/41.6.948","article-title":"Validation of abbreviated oral methionine-loading test","volume":"41","author":"Bostom","year":"1995","journal-title":"Clinical Chemistry"},{"key":"10.1053\/beha.1999.0036_RF5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(90)90058-Q","article-title":"Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment","volume":"81","author":"Brattstr\u00f6m","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1053\/beha.1999.0036_RF6","first-page":"975","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis","volume":"335","author":"Cattaneo","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0021-9150(95)05529-6","article-title":"Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart Study","volume":"116","author":"Bostom","year":"1995","journal-title":"Atherosclerosis"},{"key":"10.1053\/beha.1999.0036_RF8","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/clinchem\/39.7.1390","article-title":"Kinetics of plasma homocysteine in healthy subjects after peroral homocysteine loading","volume":"39","author":"Guttormsen","year":"1993","journal-title":"Clinical Chemistry"},{"key":"10.1053\/beha.1999.0036_RF9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/ajcn\/63.2.194","article-title":"Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency","volume":"63","author":"Guttormsen","year":"1996","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1053\/beha.1999.0036_RF10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ki.1997.359","article-title":"Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure","volume":"52","author":"Guttormsen","year":"1997","journal-title":"Kidney International"},{"key":"10.1053\/beha.1999.0036_RF11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/clinchem\/44.2.311","article-title":"Enzyme conversion immunoassay for determining total homocysteine in plasma or serum","volume":"44","author":"Frantzen","year":"1998","journal-title":"Clinical Chemistry"},{"key":"10.1053\/beha.1999.0036_RF12","first-page":"1","article-title":"The natural history of homocystinuria due to cystathionine beta-synthase deficiency","volume":"37","author":"Mudd","year":"1985","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM198509193131201","article-title":"Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease","volume":"313","author":"Boers","year":"1985","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(92)90246-D","article-title":"Age dependency of cystathionine beta-synthase activity in human fibroblasts in homocyst(e)inemia and atherosclerotic vascular disease","volume":"94","author":"Nordstrom","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1053\/beha.1999.0036_RF15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1365-2362.1995.tb01687.x","article-title":"Plasma homocysteine and menopausal status","volume":"25","author":"Wouters","year":"1995","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/0026-0495(87)90043-6","article-title":"Homocysteinemia due to folate deficiency","volume":"36","author":"Kang","year":"1987","journal-title":"Metabolism"},{"key":"10.1053\/beha.1999.0036_RF17","doi-asserted-by":"crossref","first-page":"1254S","DOI":"10.1093\/jn\/126.suppl_4.1254S","article-title":"Plasma homocysteine concentrations in a population with a low coronary heart disease prevalence","volume":"126","author":"Ubbink","year":"1995","journal-title":"Journal of Nutrition"},{"key":"10.1053\/beha.1999.0036_RF18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1086\/302015","article-title":"Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase","volume":"63","author":"Pepe","year":"1998","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM199804093381501","article-title":"Reduction of plasma homocyst(e)ine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease","volume":"338","author":"Malinow","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF20","first-page":"511","article-title":"Homocysteinemia and vascular disease in end-stage renal disease","volume":"57","author":"Dennis","year":"1996","journal-title":"Kidney International"},{"key":"10.1053\/beha.1999.0036_RF21","first-page":"828","article-title":"Plasma homocysteine in children with acute lymphoblastic leukemia: changes during a chemotherapeutic regimen including methotrexate","volume":"51","author":"Refsum","year":"1991","journal-title":"Cancer Research"},{"key":"10.1053\/beha.1999.0036_RF22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/clpt.1989.179","article-title":"Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment","volume":"46","author":"Refsum","year":"1989","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1053\/beha.1999.0036_RF23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0002-9343(97)00129-0","article-title":"Homocysteine in sickle cell disease: relationship to stroke","volume":"103","author":"Houston","year":"1997","journal-title":"American Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF24","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2141.1999.01340.x","article-title":"Homocysteine levels in polycythaemia vera and essential thrombocythaemia","volume":"105","author":"Gisslinger","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.1999.0036_RF25","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(05)60761-1","article-title":"Kilmer McCully: pioneer of the homocysteine theory","volume":"352","author":"Larkin","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.1999.0036_RF26","first-page":"111","article-title":"Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis","volume":"56","author":"McCully","year":"1969","journal-title":"American Journal of Pathology"},{"key":"10.1053\/beha.1999.0036_RF27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1172\/JCI108350","article-title":"The pathogenesis of coronary artery disease. A possible role for methionine metabolism","volume":"57","author":"Wilcken","year":"1976","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF28","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0026-0495(83)90045-8","article-title":"Homocysteinemia, ischemic heart disease, and the carrier state for homocystinuria","volume":"32","author":"Wilcken","year":"1983","journal-title":"Metabolism"},{"key":"10.1053\/beha.1999.0036_RF29","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/01.STR.15.6.1012","article-title":"Moderate homocysteinemia\u2014a possible risk factor for arteriosclerotic cerebrovascular disease","volume":"15","author":"Brattstr\u00f6m","year":"1984","journal-title":"Stroke"},{"key":"10.1053\/beha.1999.0036_RF30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0735-1097(85)80473-3","article-title":"Methionine intolerance: a possible risk factor for coronary artery disease","volume":"6","author":"Murphy-Chutorian","year":"1985","journal-title":"Journal of the American College of Cardiologists"},{"key":"10.1053\/beha.1999.0036_RF31","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJM199104253241701","article-title":"Hyperhomocysteinemia: an independent risk factor for vascular disease","volume":"324","author":"Clarke","year":"1991","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF32","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1172\/JCI112461","article-title":"Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease","volume":"77","author":"Kang","year":"1986","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF33","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/0735-1097(90)90542-W","article-title":"Plasma homocyst(e)ine levels in men with premature coronary artery disease","volume":"16","author":"Genest","year":"1990","journal-title":"Journal of the American College of Cardiologists"},{"key":"10.1053\/beha.1999.0036_RF34","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/jama.1992.03490070059042","article-title":"A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians","volume":"268","author":"Stampfer","year":"1992","journal-title":"JAMA"},{"key":"10.1053\/beha.1999.0036_RF35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/ije\/24.4.704","article-title":"Serum total homocysteine and coronary heart disease","volume":"24","author":"Arnesen","year":"1995","journal-title":"International Journal of Epidemiology"},{"key":"10.1053\/beha.1999.0036_RF36","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","article-title":"A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes","volume":"274","author":"Boushey","year":"1995","journal-title":"JAMA"},{"key":"10.1053\/beha.1999.0036_RF37","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.1997.03540460039030","article-title":"Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project","volume":"277","author":"Graham","year":"1997","journal-title":"JAMA"},{"key":"10.1053\/beha.1999.0036_RF117","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.STR.21.4.572","article-title":"Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke","volume":"21","author":"Coull","year":"1990","journal-title":"Stroke"},{"key":"10.1053\/beha.1999.0036_RF38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2362.1992.tb01829.x","article-title":"Hyperhomocysteinemia in stroke: prevalence, cause, and relationships to type of stroke and stroke risk factors","volume":"22","author":"Brattstr\u00f6m","year":"1992","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF39","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0002-9394(14)73919-4","article-title":"Hyperhomocysteinemia in retinal artery and retinal vein occlusion","volume":"115","author":"Wenzler","year":"1993","journal-title":"American Journal of Ophthalmology"},{"key":"10.1053\/beha.1999.0036_RF40","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/01.STR.25.10.1924","article-title":"A prospective study of plasma homocyst(e)ine and risk of ischemic stroke","volume":"25","author":"Verhoef","year":"1994","journal-title":"Stroke"},{"key":"10.1053\/beha.1999.0036_RF41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2796.1992.tb00535.x","article-title":"Hyperhomocyst(e)inaemia: an independent risk factor for intermittent claudication","volume":"231","author":"Molgaard","year":"1992","journal-title":"Journal of Internal Medicine"},{"key":"10.1053\/beha.1999.0036_RF42","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1161\/01.CIR.79.6.1180","article-title":"Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease","volume":"79","author":"Malinow","year":"1989","journal-title":"Circulation"},{"key":"10.1053\/beha.1999.0036_RF43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0741-5214(91)90020-U","article-title":"The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease","volume":"13","author":"Taylor","year":"1991","journal-title":"Journal of Vascular Surgery"},{"key":"10.1053\/beha.1999.0036_RF44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000216202","article-title":"Plasma homocysteine in venous thromboembolism","volume":"21","author":"Brattstr\u00f6m","year":"1991","journal-title":"Haemostasis"},{"key":"10.1053\/beha.1999.0036_RF45","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1161\/01.ATV.14.7.1080","article-title":"High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis","volume":"14","author":"Falcon","year":"1994","journal-title":"Arteriosclerosis and Thrombosis"},{"key":"10.1053\/beha.1999.0036_RF46","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/01.ATV.15.9.1321","article-title":"Plasma homocysteine levels in patients with deep venous thrombosis","volume":"15","author":"Amundsen","year":"1995","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1053\/beha.1999.0036_RF47","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(95)90008-X","article-title":"Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?","volume":"345","author":"den Heijer","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/beha.1999.0036_RF48","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis","volume":"334","author":"den Heijer","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF49","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1055\/s-0038-1650680","article-title":"Hyperhomocysteinemia and deep-vein thrombosis. A case-control study","volume":"76","author":"Simioni","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.1999.0036_RF50","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1001\/archinte.158.19.2101","article-title":"Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease","volume":"158","author":"Ray","year":"1998","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/beha.1999.0036_RF51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJM199603213341204","article-title":"Coexistence of hereditary homocystinuria and factor V Leiden\u2014effect on thrombosis","volume":"334","author":"Mandel","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF52","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.95.7.1777","article-title":"Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism","volume":"95","author":"Ridker","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/beha.1999.0036_RF53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM199607253350415","article-title":"Thrombophilia, homocystinuria, and mutation of the factor V gene","volume":"335","author":"D'Angelo","year":"1996","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF54","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1182\/blood.V91.6.2015","article-title":"Homozygous cystathionine beta-synthase deficiency, combined with factor V Leiden or thermolabile methylenetetrahydrofolate reductase in the risk of venous thrombosis","volume":"91","author":"Kluijtmans","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.1999.0036_RF55","first-page":"414","article-title":"Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase","volume":"43","author":"Kang","year":"1988","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0026-0495(88)90076-5","article-title":"Thermolabile methylenetetrahydrofolate reductase in patients with coronary artery disease","volume":"37","author":"Kang","year":"1988","journal-title":"Metabolism"},{"key":"10.1053\/beha.1999.0036_RF57","first-page":"536","article-title":"Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease","volume":"48","author":"Kang","year":"1991","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF58","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/01.CIR.88.4.1463","article-title":"Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease","volume":"88","author":"Kang","year":"1993","journal-title":"Circulation"},{"key":"10.1053\/beha.1999.0036_RF59","first-page":"142","article-title":"Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia","volume":"56","author":"Engbersen","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ng0694-195","article-title":"Human methylenetetrahydrofolate reductase: Isolation of cDNA, mapping and mutation identification","volume":"7","author":"Goyette","year":"1994","journal-title":"Nature Genetics"},{"key":"10.1053\/beha.1999.0036_RF61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","article-title":"A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase","volume":"10","author":"Frosst","year":"1995","journal-title":"Nature Genetics"},{"key":"10.1053\/beha.1999.0036_RF62","first-page":"262","article-title":"Elevated total plasma homocysteine and 667C\u2192T mutation of the 5,10-methylenetetrahydrofolate reductase gene in thrombotic vascular disease","volume":"59","author":"de Franchis","year":"1996","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF63","first-page":"229","article-title":"Differences in methylenetetrahydrofolate reductase genotype frequencies between white and blacks","volume":"60","author":"Stevenson","year":"1997","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF64","first-page":"35","article-title":"Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease","volume":"58","author":"Kluijtmans","year":"1996","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF65","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1161\/01.CIR.94.10.2410","article-title":"Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians","volume":"94","author":"Ma","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/beha.1999.0036_RF66","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1161\/01.CIR.93.1.7","article-title":"Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations","volume":"93","author":"Jacques","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/beha.1999.0036_RF67","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/qjmed\/89.8.571","article-title":"The common \u2018thermolabile\u2019 variant of methylene tetrahydrofolate reductase is a major determinant of mild hyperhomocysteinaemia","volume":"89","author":"Harmon","year":"1996","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF68","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1161\/01.ATV.17.3.569","article-title":"Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease","volume":"17","author":"Christensen","year":"1997","journal-title":"Arteriosclerosis, Thrombosis and Vascular Biology"},{"key":"10.1053\/beha.1999.0036_RF69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0021-9150(97)00084-1","article-title":"The 677C\u2192T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease","volume":"132","author":"Verhoef","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1053\/beha.1999.0036_RF70","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.95.1.21","article-title":"Methylenetetrahydrofolate reductase gene and coronary artery disease","volume":"95","author":"van Bockxmeer","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/beha.1999.0036_RF71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-0037-1615053","article-title":"The high prevalence of thermolabile 5-10-methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD)","volume":"79","author":"Abbate","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.1999.0036_RF72","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.98.23.2520","article-title":"Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis","volume":"98","author":"Brattstr\u00f6m","year":"1998","journal-title":"Circulation"},{"key":"10.1053\/beha.1999.0036_RF73","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0038-1656059","article-title":"The mutation Ala677\u2192Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis","volume":"77","author":"Arruda","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.1999.0036_RF74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1365-2141.1998.00935.x","article-title":"Effect of the MTHFRC677T variant on risk of venous thromboembolism: interaction with factor V Leiden and prothrombin (F2G20210A) mutations","volume":"103","author":"Brown","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.1999.0036_RF75","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0038-1657542","article-title":"Thrombophilia as a multigenic disorder","volume":"78","author":"Seligsohn","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.1999.0036_RF76","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00001721-199809000-00015","article-title":"Mild hyperhomocysteinemia and MTHFR C677T do not increase the risk for venous thrombosis in a Spanish population","volume":"9","author":"Vargas","year":"1998","journal-title":"Blood Coagulation & Fibrinolysis"},{"key":"10.1053\/beha.1999.0036_RF77","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2141.1997.1422957.x","article-title":"The VITA project: C677T mutation in the methylene-tetrahydrofolate reductase gene and risk of venous thromboembolism","volume":"97","author":"Tosetto","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.1999.0036_RF118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00001721-199903000-00007","article-title":"No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene","volume":"10","author":"Rintelen","year":"1999","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1053\/beha.1999.0036_RF78","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/mgme.1998.2714","article-title":"A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity","volume":"64","author":"Weisberg","year":"1998","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1053\/beha.1999.0036_RF79","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1086\/301825","article-title":"A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?","volume":"62","author":"van der Put","year":"1998","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.1999.0036_RF80","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2141.1999.01254.x","article-title":"A second mutation in the methylenetetrahydrofolate reductase gene and the risk of venous thrombotic disease","volume":"105","author":"Franco","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.1999.0036_RF81","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1056\/NEJM197409122911101","article-title":"Homocystinemia: Vascular injury and arterial thrombosis","volume":"291","author":"Harker","year":"1968","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF82","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM198209233071303","article-title":"Kinetics and distribution of111indium-labeled platelets in patients with homocystinuria","volume":"307","author":"Hill-Zobel","year":"1982","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF83","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM197612022952303","article-title":"Platelet survival and morphology in homocystinuria due to cystathionine synthase deficiency","volume":"295","author":"Uhlemann","year":"1976","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF84","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1172\/JCI116715","article-title":"Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism","volume":"92","author":"Di Minno","year":"1993","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF85","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1203\/00006450-198206000-00018","article-title":"Effect of homocysteine and homocystine on platelet and vascular arachidonic acid metabolism","volume":"16","author":"Graeber","year":"1982","journal-title":"Pediatric Research"},{"key":"10.1053\/beha.1999.0036_RF86","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1126\/science.162.3857.1007-a","article-title":"Activation of Hageman factor by L -homocystine","volume":"162","author":"Ratnoff","year":"1968","journal-title":"Science"},{"key":"10.1053\/beha.1999.0036_RF87","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3476(83)80247-9","article-title":"Diet-responsive proconvertin (factor VII) deficiency in homocystinuria","volume":"102","author":"Munnich","year":"1983","journal-title":"Journal of Pediatrics"},{"key":"10.1053\/beha.1999.0036_RF88","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(75)91870-X","article-title":"Antithrombin activity in homocystinuria","volume":"i","author":"Giannini","year":"1975","journal-title":"Lancet"},{"key":"10.1053\/beha.1999.0036_RF89","first-page":"24","article-title":"Lowered antithrombin III activity and other clotting changes in homocystinuria: effects of a pyridoxine-folate regimen","volume":"19","author":"Palareti","year":"1989","journal-title":"Haemostasis"},{"key":"10.1053\/beha.1999.0036_RF90","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/01.ATV.13.9.1327","article-title":"Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells","volume":"13","author":"Fryer","year":"1993","journal-title":"Arteriosclerosis and Thrombosis"},{"key":"10.1053\/beha.1999.0036_RF91","doi-asserted-by":"crossref","first-page":"10193","DOI":"10.1073\/pnas.89.21.10193","article-title":"Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism","volume":"89","author":"Harpel","year":"1992","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.1999.0036_RF92","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0049-3848(80)90175-9","article-title":"Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury","volume":"18","author":"Wall","year":"1980","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.1999.0036_RF93","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2362.1983.tb00121.x","article-title":"Endothelial cell dysfunction in homocystinuria","volume":"13","author":"de Groot","year":"1983","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF94","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1172\/JCI116712","article-title":"Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells","volume":"92","author":"Nishinaga","year":"1993","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF95","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1172\/JCI112519","article-title":"Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator","volume":"77","author":"Rodgers","year":"1986","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF96","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V75.4.895.895","article-title":"Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells","volume":"75","author":"Rodgers","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.1999.0036_RF97","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1172\/JCI115514","article-title":"Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine","volume":"88","author":"Lentz","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF98","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1073\/pnas.91.14.6369","article-title":"Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis","volume":"91","author":"Tsai","year":"1994","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.1999.0036_RF99","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0008-6363(97)00048-5","article-title":"Homocysteine induces synthesis of a serine elastase in arterial smooth muscle cells from multi-organ donors","volume":"34","author":"Jourdheuil","year":"1997","journal-title":"Cardiovascular Research"},{"key":"10.1053\/beha.1999.0036_RF100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI116187","article-title":"Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen","volume":"91","author":"Stamler","year":"1993","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.1999.0036_RF101","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/0268-9499(94)90257-7","article-title":"Pathobiochemical implications of hyperhomocysteinaemia","volume":"8","author":"Blom","year":"1996","journal-title":"Fibrinolysis"},{"key":"10.1053\/beha.1999.0036_RF102","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1073\/pnas.92.5.1585","article-title":"Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia","volume":"92","author":"Watanabe","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.1999.0036_RF103","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0404.1994.tb05406.x","article-title":"Effects of the disruption of transmethylation in the central nervous system: an animal model","volume":"154","author":"Scott","year":"1994","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1053\/beha.1999.0036_RF104","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/S0140-6736(95)91743-8","article-title":"Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida","volume":"346","author":"van der Put","year":"1995","journal-title":"Lancet"},{"key":"10.1053\/beha.1999.0036_RF105","first-page":"4862","article-title":"A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer","volume":"56","author":"Chen","year":"1996","journal-title":"Cancer Research"},{"key":"10.1053\/beha.1999.0036_RF106","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.ATV.13.9.1253","article-title":"Disordered methionine\/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology","volume":"13","author":"Dudman","year":"1993","journal-title":"Arteriosclerosis and Thrombosis"},{"key":"10.1053\/beha.1999.0036_RF107","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM198308253090802","article-title":"Homocystinuria\u2014the effects of betaine in the treatment of patients not responsive to pyridoxine","volume":"309","author":"Wilcken","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF108","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/0026-0495(85)90156-8","article-title":"Homocystinuria due to cystathionine beta-synthase deficiency\u2014the effects of betaine treatment in pyridoxine-responsive patients","volume":"34","author":"Wilcken","year":"1985","journal-title":"Metabolism"},{"key":"10.1053\/beha.1999.0036_RF109","doi-asserted-by":"crossref","first-page":"1273S","DOI":"10.1093\/jn\/126.suppl_4.1273S","article-title":"Treatment of hyperhomcyst(e)inemia: physiological basis","volume":"126","author":"Kang","year":"1996","journal-title":"Journal of Nutrition"},{"key":"10.1053\/beha.1999.0036_RF110","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0049-3848(93)90153-F","article-title":"Elevated total plasma homocysteine, a risk factor for thrombosis. Relation to coagulation and fibrinolytic parameters","volume":"70","author":"Bienvenu","year":"1993","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.1999.0036_RF111","first-page":"530","article-title":"Interactions between homocysteineaemia and conventional risk factors in vascular disease","volume":"15","author":"Graham","year":"1994","journal-title":"European Heart Journal"},{"key":"10.1053\/beha.1999.0036_RF112","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1093\/clinchem\/40.4.552","article-title":"Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease","volume":"40","author":"Wu","year":"1994","journal-title":"Clinical Chemistry"},{"key":"10.1053\/beha.1999.0036_RF113","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9150(94)90078-7","article-title":"Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study","volume":"106","author":"Alfthan","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1053\/beha.1999.0036_RF114","first-page":"1632","article-title":"Plasma homocysteine levels and mortality in patients with coronary artery disease","volume":"337","author":"von Eckardstein","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.1999.0036_RF115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0021-9150(88)90147-5","article-title":"Homocysteine and myocardial infarction","volume":"71","author":"Israellson","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1053\/beha.1999.0036_RF116","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0950-821X(05)80255-5","article-title":"Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50\u2014effect of smoking and extent of disease","volume":"7","author":"Bergmark","year":"1993","journal-title":"European Journal of Vascular Surgery"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692699900361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692699900361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T17:19:54Z","timestamp":1583428794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692699900361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,9]]},"references-count":118,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,9]]}},"alternative-id":["S1521692699900361"],"URL":"https:\/\/doi.org\/10.1053\/beha.1999.0036","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[1999,9]]}}}